Potomac Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33M Buy
5,022
+1,354
+37% +$357K 0.03% 49
2026
Q2
$932K Buy
3,668
+497
+16% +$116K 0.02% 56
2026
Q1
$775K Sell
3,171
-391
-11% -$91.1K 0.03% 57
2025
Q4
$737K Sell
3,562
-520
-13% -$103K 0.03% 60
2025
Q3
$757K Sell
4,082
-228
-5% -$39.1K 0.03% 61
2025
Q2
$710K Sell
4,310
-225
-5% -$34.6K 0.04% 58
2025
Q1
$712K Buy
4,535
+216
+5% +$33.8K 0.31% 40
2024
Q4
$625K Buy
+4,319
New +$669K 0.04% 60

Other funds holding JNJ

Potomac Fund Management's JNJ Position: Q3 2026 in Review

Potomac Fund Management increased its Johnson & Johnson (JNJ) stake by 37% in Q3 2026, buying an estimated $357K and bringing the position to 5,022 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #49.

Potomac Fund Management first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Potomac Fund Management held 5,022 shares of Johnson & Johnson worth $1.33M as of Q3 2026.
  • Potomac Fund Management bought 1,354 Johnson & Johnson shares in Q3 2026, an estimated $357K.
  • Johnson & Johnson made up 0.03% of Potomac Fund Management's portfolio in Q3 2026, its #49 holding.
  • Potomac Fund Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Potomac Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.